Summary
The antibacterial activity of the oxacephalosporin flomoxef was evaluated in comparison to cefpirome, cefuzoname, cefotaxime, ceftazidime, and imipenem against fresh clinical isolates. Flomoxef is an antibiotic with strong antibacterial activity against staphylococci including methicillin-resistant strains and streptococci with the exception ofEnterococcus faecalis andEnterococcus faecium. It is very active against gram-negative cocci and rods including gram-positive and gram-negative anaerobes. AgainstPseudomonas sp. flomoxef has no activity.
Zusammenfassung
Verglichen wurde dieIn-vitro-Aktivität von Flomoxef, Cefpirom, Cefuzonam, Cefotaxim, Ceftazidim und Imipenem gegenüber frischen klinischen Stämmen. Flomoxef zeigt eine starke antibakterielle Aktivität gegenüber Staphylokokken (auch Methicillin resistente) und Streptokokken mit der Ausnahme vonEnterococcus faecalis undEnterococcus faecium. Es ist ebenfalls aktiv gengenüber aeroben und anaeroben gram-negativen und gram-positiven Stäbchen und Kokken. Resistent sind Pseudomonaden.
Similar content being viewed by others
References
Murakami, K., Nomura, K., Doi, M., Yoshida, T. Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistantStaphylococcus aureus. Antimicrob. Agents Chemother. 31 (1987) 1307–1311.
Shimada, K., Inamatsu, T., Urayama, K., Oka, S., Adachi, K., Kamijo, H. Antimicrobial activities, pharmacokinetics and clinical evaluation of 6315-S (flomoxef). Chemotherapy (Tokyo) 35 (1987) 649–655.
Yazawa, K., Mikami, Y., Uno, J., Otozai, K., Arai, T. In vitro activity of flomoxef, a new oxacephem group antibiotic against Nocardia in comparison with other cephalosporins. J. Antimicrob. Chemother. 24 (1989) 921–925.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shah, P.M., Knothe, H. The in vitro activity of flomoxef compared to four other cephalosporins and imipenem. Infection 19 (Suppl 5), S279–S283 (1991). https://doi.org/10.1007/BF01645540
Issue Date:
DOI: https://doi.org/10.1007/BF01645540